Promoting Excellence in Diabetes Care

Member Login

Australasian Diabetes Advancements and Technologies Summit

ADATS

REGISTER NOW FOR THE SUPER EARLY BIRD RATE
REGISTER NOW

Join us for the eagerly awaited 9th annual Australasian Diabetes Advancements and Technologies Summit (ADATS) at the Sofitel Gold Coast, leading the way for the upcoming Australian Diabetes Congress. Prepare for an inspiring day featuring renowned international speakers and leading Australian experts as we explore the future and application of diabetes technologies locally and globally.

We are currently securing an exciting lineup of speakers, including Prof Emma Wilmot (UK), Prof Othmar Moser (GER) and Dr Thomas Grace and plenty more to come!

Whether you’re new to diabetes care or an experienced professional, this event offers valuable insights for everyone dedicated to improving the lives of individuals with diabetes. Discover the program details at www.nadc.net.au/adats and be part of this not-to-be-missed event.

NOTE: Registration to ADATS is via the Australasian Diabetes Congress (ADC) registration page. You can register for ADATS without registering for ADC or do both at the same time.

If you require further assistance with registering for ADATS 2025, please feel free to email Lei or Marj at admin@nadc.net.au

MEET OUR SPEAKERS
CLICK HERE TO VIEW ADATS 2025 PROGRAM

DID YOU MISS ADATS 2024?

Watch ADATS full presentations on your computer, tablet, or smartphone at your own pace.

AUSTRALASIAN DIABETES ADVANCEMENTS & TECHNOLOGIES SUMMIT (ADATS) 

The main topics that are discussed at ADATS include:

  • New therapeutics in diabetes tech
  • CGM Metrics – The new standard
  • Priority populations and technology 
  • Keeping it real
REGISTER NOW & WATCH ADATS ON DEMAND

MEET OUR 2025 SPEAKERS

BREAKFAST SESSION

Tracey Stamates-Roerty

Driving Better TIR and TITR with Control-IQ Technology

🕒 7:15 – 8:15

MORE INFORMATION

ADATS PLENARY SESSIONS

Dr Thomas Grace

CGM as a behaviour change tool in primary care

🕒 8:40 – 9:00

MORE INFORMATION

A/Prof Emma Wilmot

Using CGM for diabetes management type 2, what is the evidence

🕒 9:00 – 9:20

MORE INFORMATION

Dr Gaurav Puri

Getting it Right First Time (GIRFT)

🕒 9:20 – 9:40

MORE INFORMATION

Prof Othmar Moser

Exercise with mylife CamAPS FX: from recommendations to individualised solutions

🕒 9:40 – 10:00

MORE INFORMATION

A/Prof Neale Cohen

CLOSE-IT Results from randomised fully closed-loop trial

🕒 10:30 – 10:45

MORE INFORMATION

Prof Liz Davis

Pumps for kids from diagnosis – early study outcomes

🕒 10:45 – 11:00

MORE INFORMATION

Dr Jessica Triay

Diabetes Dashboards – What are they, how are they used and what is the evidence that they change care our behaviour?

🕒 11:30 – 11:15

MORE INFORMATION

A/Prof Tien-Ming Hng

Dashboards in Diabetes Care – do they improve care?

🕒 11:15 – 11:30

MORE INFORMATION

Dr Anish Menon

Rethinking models of outpatient diabetes care using eHealth in primary care

🕒 11:30 – 11:45

MORE INFORMATION

Tracy Pickett

Law and AI in healthcare – what do we need to be aware of in this new era, locally and more broadly

🕒 12:50 – 1:10

MORE INFORMATION

Dr Benjamin Sly

AI for diabetes in the hospital where are we now and where are we going?

🕒 1:10 – 3:00

MORE INFORMATION

Dr Matthew Cohen

AI scribes in the clinic: live demo

🕒 1:30 – 1:50

MORE INFORMATION

Alison Bennett

Live Demo: Meal planning using AI      

🕒 1:50 – 2:00

MORE INFORMATION

Leon Tribe

Using AI to read CGM Reports in 20 Minutes – Fact or Fiction?

🕒 2:00 – 2:20

MORE INFORMATION

Dr Bruce King

Flying high and low – the effects of flying on insulin infusion rates

🕒 3:10 – 3:25

MORE INFORMATION

Lauren Cusack

Getting through the gates – airport security and diabetes technology

🕒 3:25 – 3:40

MORE INFORMATION

A Prof Tony Huynh

Diabetes tech in the classroom and schoolyard

🕒 3:40 – 3:55

MORE INFORMATION

Dr Liz Holmes Truscott

From burden to belonging: Exploring the psychosocial impacts of diabetes tech

🕒 3:55 – 4:10

MORE INFORMATION

Prof Stephen Twigg

ADS launches standards for diabetes and liver disease – what tech will support us to do better?

🕒 4:10 – 4:30

MORE INFORMATION

MEET OUT SPONSORS

GOLD SPONSORS

MORE INFORMATION
MORE INFORMATION
MORE INFORMATION
MORE INFORMATION
MORE INFORMATION
MORE INFORMATION

TRADE PARTNERS

MORE INFORMATION
MORE INFORMATION
MORE INFORMATION

I would like to receive updates on ADATS 2024

DID YOU MISS ADATS 2023? 

WATCH THE NADC ADATS 2023 ON DEMAND!

REGISTER TO WATCH ON DEMAND

Watch ADATS full presentations on your computer, tablet, or smartphone at your own pace.

AUSTRALASIAN DIABETES ADVANCEMENTS & TECHNOLOGIES SUMMIT (ADATS) 

The main topics that are discussed at ADATS include:

  • What’s new in Diabetes Technology
  • The complexities, intricacies, and disparities of diabetes technology
  • Quick bytes Session

VIEW PROGRAM HERE

PAST ADATS

ADATS was launched for healthcare professionals in Australia in 2017, to provide an access to the latest information on diabetes advancements and technologies. The event is the result of the commitment by the NADC to improve the knowledge and skills of healthcare professionals in Australia. ADATS brings together world-leading experts, academics and clinicians with a shared focus and passion in advanced technologies and therapeutics in diabetes.

The event is the result of the commitment of the NADC to improve the knowledge and skills of healthcare professionals in Australia in the area of diabetes and technology.

ADATS 2020

ADATS 2017

ADATS 2019

ADATS 2018

NADC LOGO

The National Association of Diabetes Centres (NADC) is a national collective of organisations that are involved either directly or indirectly in diabetes services and care.

Quick Links
Other Links
Contact us
Facebook
Twitter
Linkedin
Instagram
Youtube
Apple
Copyright ©2024 National Association of Diabetes Centres. All Rights Reserved

Tracey Stamates - Roerty

Driving Better TIR and TITR with Control-IQ Technology

Biography

Tracey Stamates-Roerty, RD, LD, CDCES has worked in the nutrition and diabetes field for over 25 years as a registered dietitian, as well as a certified diabetes care and education specialist. Tracey has been working at Tandem Diabetes Care since 2014 and has helped to launch all of the products that Tandem Diabetes has distributed in the United States. During her time at Tandem, she has evolved from a direct patient care trainer to managing the clinical staff of 6 states in the United States. In 2021, Tracey joined the International Team for Tandem to provide clinical support to the expanding international markets. She currently serves as the Senior Manager of International Clinical Support and has a passion for understanding the intricacies of the Control-IQ technology algorithm and improving patient outcomes by using the data provided through software platforms to optimize the use of the system.

Tracey Stamates-Roerty, RD, LD, CDCES has worked in the nutrition and diabetes field for over 25 years as a registered dietitian, as well as a certified diabetes care and education specialist. Tracey has been working at Tandem Diabetes Care since 2014 and has evolved from a direct patient trainer to now holding the position of Senior Manager of International Support. She has a passion for understanding the intricacies of the Control-IQ technology algorithm and improving patient outcomes by using the data provided through software platforms to optimize the use of the system.

Prof. Othmar Moser

Exercise with mylife CamAPS FX: from recommendations to individualised solutions

Biography

Othmar Moser is a Full Professor of Sports Medicine at the University of Bayreuth (Germany) and works at the outpatient clinic for diabetes, physical activity, and exercise at the Medical University of Graz (Austria).

His research focuses on lifestyle interventions for individuals with diabetes, overweight, or obesity. He explores the integration of diabetes technology into healthy lifestyle strategies to enhance therapy outcomes and quality of life for people living with diabetes. Othmar was the lead author of the 2020 EASD/ISPAD position paper on continuous glucose monitoring (CGM), exercise, and type 1 diabetes, and also led the recently published 2025 EASD/ISPAD position paper on automated insulin delivery (AID) systems and exercise in type 1 diabetes.

He has authored over 200 scientific publications in the field of exercise and diabetes.

A/Prof Neale Cohen

CLOSE-IT Results from randomised fully closed-loop trial

Biography

Associate Professor Neale Cohen is an endocrinologist, clinical Researcher and head of the Diabetes Clinical Research Laboratory at the Baker Heart and Diabetes Institute. He is currently Director of Clinical Services, and a consultant physician at the Baker, as well as holding an Adjunct Clinical Associate Professor position with the School of Public Health and Preventative Medicine, Monash University, and Associate Professor, School of Pharmacy, University of Queensland. He leads strategy, development and management of the Diabetes Specialist Services at the Baker, including diabetes, obesity, respiratory and ophthalmology services, a Victorian telehealth service and a satellite service in western Melbourne.


His research focus includes technology and management of Type 1 diabetes, Type 2 diabetes therapeutics, and indigenous diabetes.

Session Description

Closing the loop -are we there yet? This session will present the findings of the CLOSE IT trial, a fully closed-loop study in people living with type 1 diabetes.

Prof Liz Davis

Pumps for kids from diagnosis - early study outcomes

Biography

The Kids Research Institue Australia & Perth Children’s Hospital
Co-Director Children’s Diabetes Centre & Head of Department Endocrinology

Professor Elizabeth Davis has had a career of integrating clinical care and diabetes research based in Perth, Australia. She is Head of the Department of Endocrinology and Diabetes at Perth Children’s Hospital (PCH) and co-directs the Children’s Diabetes Centre at The Kids Research Institue Australia

Professor Davis is a past President of the Australasian Paediatric Endocrine Group. She leads the Australasian hub of SWEET, an international paediatric diabetes initiative with the goal of improving outcomes for children with diabetes globally.

Jessica Triay

Diabetes Dashboards - What are they, how are they used and what is the evidence that they change care or behaviour?

Biography

Jessica undertook Endocrinology training in the UK, with a sabbatical year at the Mayo Clinic (Minn, USA) and completion of an Executive MBA in Health Service Management.

She worked in regional Victoria in Bendigo Health before joining the Gold Coast University Hospital and Health Service team in December 2023. She is the lead for Diabetes Service Development.

Session Description

An introduction to patient dashboards. What they are and the evidence supporting their use.

Dr Matthew Cohen

AI scribes in the clinic: live demo

Biography

Dr Matt Cohen is a consultant physician who has been specialising in diabetes care and education since 1980. He was the inaugural Director of Medical Services at the International Diabetes Institute (now the Baker Heart & Diabetes Institute) from 1986 – 2007, and conducts a full-time private practice at Baker.

He has a keen interest in the applications of technology to diabetes care.

He pioneered the introduction of self-blood glucose monitoring in Australia, and developed a wide range of educational and professional resources, including a postgraduate training program for general practitioners. He is author of 59 publications, including 8 editions of Diabetes – a Handbook of Diabetes Management, and wrote the FlexIT –flexible insulin therapy booklet and patient training program.

Dr Cohen is married and has 2 daughters and 5 grandchildren. His hobbies include cycling, bridge and music, so if the projector breaks down, he can always entertain us on the piano.

Session Description

AI scribes are increasingly being used by GPs, specialists, health professionals and anyone needing to summarise and/or report on client consults. The pros and cons of AI scribes will be discussed together with a live illustrative demonstration.

Leon Tribe

Using AI to read CGM Reports in 20 Minutes - Fact or Fiction?

Biography

Leon Tribe is a passionate diabetes advocate and active researcher. His online writing focusses on providing clear explanations to people with diabetes on the disease, the latest research and innovations, and its management. Leon’s research focusses on the application of technology, and motivational models from the corporate world to diabetes management. Leveraging his knowledge and experience in information technology and professional consultancy, a first class honours degree in physics, and an MBA in strategy and leadership, he looks to empower both health care professionals and people living with diabetes. His advocacy and passion has been recognised by his acceptance into both the Diabetes Australia Community Advisory Council, and the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC) Community Engagement Panel, as well as the #dedoc° voice, and Diabetes Australia Voice programs.

Leon is an effective communicator, both in the written and spoken word, has been published in The Lancet and Diabetes Management Journal, and regularly presents at international diabetes conferences such as ATTD.

Session Description

Ten years ago, to identify a bird in a photo would have taken a team of developers and months of coding. Today, it can be done in seconds with ChatGPT.

So is ChatGPT the answer to all our problems? In this presentation, Leon will show how we can, instead of using ChatGPT, build a bot with no code which can analyse medical imagery, present a diagnosis and advise a patient instantly. He will also explain why the effort may be worth it from a governance, security, and accuracy perspective.

By the end of this session, you will have an understanding of how to set up your own image analysis bot, and what you should be thinking about when choosing the right AI technology to solve your need.

Dr Bruce King

Flying High & Low. The Effects of Flying on Insulin Infusion Rates

Biography

Bruce is the Lead of Discipline Paediatric Diabetes and Endocrinology at John Hunter Children’s Hospital which directly cares for 400 children with type 1 diabetes and manages another 300 children in regional and remote Australia. Bruce has published over 100 peer reviewed research articles.

Session Description

We will describe the impact of altitude changes on insulin delivery from pumps.

Lauren Cusack

Getting through the gates - airport security and diabetes technology

Biography

Lauren is a dedicated professional with a passion for health promotion, improving lives, community engagement & advocacy for all people living with diabetes. As the Health Promotion & Communications Manager at PDC Health Hub, she develops impactful communications, programs and services for the diabetes (and wider) community. Having been diagnosed with Type 1 diabetes at the age of 28, and growing up with a mother with T1D, Lauren brings her lived experience and deep understanding of the condition to her work each day. She is an active member of the PDC Collective, a peer support and advocacy group.

She also leads numerous advocacy projects and is an active member of steering groups and advisory groups working tirelessly to bring awareness and positive change to the world of diabetes.

Session Description

Travel should be empowering & fun – not stressful! Yet for many people living with diabetes, airport security is a source of stress and uncertainty. This session explores the unique challenges faced by people using diabetes technology such as insulin pumps and continuous glucose monitors (CGMs) when navigating airport security. Drawing on real-world experiences and advocacy efforts, this presentation will highlight the gaps in awareness and consistency across security procedures, the psychosocial impact on travellers, and the steps being taken to create change. Attendees will gain practical insights, hear about recent advocacy wins, and walk away with strategies to better support people with diabetes in preparing for safe and confident travel.

Dr Liz Holmes - Truscott

From burden to belonging: Exploring the psychosocial impacts of diabetes tech.

Biography

Dr Elizabeth Holmes-Truscott is Deputy Director of the Australian Centre for Behavioural Research in Diabetes (a partnership between Diabetes Victoria and Deakin University), Behavioural Platform lead for the Australian Centre for Accelerating Diabetes Innovations Research Centre, and co-lead of the End Diabetes Stigma International Consensus and Global Summit. Elizabeth leads a program of applied research examining psychosocial aspects of diabetes, including a focus on understanding and reducing diabetes stigma and other barriers to optimal self-care.

She advocates for community involvement in all stages of research and the assessment of person-reported outcomes and experiences alongside biomedical markers.

Session Description

Original title: One size does not fit all – the mental burden of diabetes tech.
Suggested title: From burden to belonging: Exploring the psychosocial impacts of diabetes tech.

Revised title incorporates both the psychological and social impacts of diabetes tech, along with benefits and burdens.

The presentation will evidence the need for person-centered and empathic care, highlight the importance of exploring person-reported outcomes and experiences of tech, and discuss the role of tech in reinforcing or addressing diabetes stigma and discrimination (e.g. via visibility)

Prof Stephen Twigg

ADS launches standards for diabetes and liver disease - what tech will support us to do better?

Biography
Session Description

GOLD SPONSOR: ABBOTT

At Abbott, we’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help you get back to doing what you love.

With headquarters in north suburban Chicago, we serve people in more than 160 countries with leading medical devices, diagnostics, nutrition products and branded generic medicines. Our 113,000 colleagues are helping millions of people to live better and healthier, every day around the world.

🌐https://www.aus.abbott/

GOLD SPONSOR: AMSL DEXCOM

AMSL Diabetes, a Dexcom company distribute the Dexcom Continuous Glucose Monitoring (CGM) Systems, Tandem Insulin Pumps, Glooko diabetes management software and HypoPak fast acting glucose kits.

For over 20 years we’ve given thousands of people the tools and support they need to improve their quality of life. For more information on our product range, please visit our trade display

🌐https://dexcom.com.au

GOLD SPONSOR: NOVONORDISK

Novo Nordisk A/S is a leading global healthcare company, founded in 1923 and headquartered in Denmark.

Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk A/S employs about 61,400 people in 80 countries and markets its products in around 170 countries.

Novo Nordisk A/S recognizes the significant value of working in partnership with patients, policymakers,
healthcare professionals and non-governmental organizations to understand priority areas and provide help where it is needed most.

🌐 https://www.novonordisk.com.au/

GOLD SPONSOR: SANOFI

Sanofi. We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.

Scientific discoveries don’t happen overnight or without hard work. But our determination to find answers for patients motivates us to develop breakthrough medicines and vaccines. And to never settle.

Learn more at sanofi.com.au.

very day around the world.

🌐 https://www.sanofi.com/en/australia

GOLD SPONSOR: YPSOMED

Ypsomed Australia is the Australian affiliate of Ypsomed AG, a Swiss-based company with a deep heritage in the development and manufacture of infusion and injection systems for self-medication, including insulin therapy. With over 40 years’ experience in bringing insulin-delivery devices to market.

Ypsomed understands the challenges people on insulin therapy face in their everyday life, and is committed to making a difference through the design and delivery of high quality innovative & intuitive products and services that aim to make life with diabetes easier.

🌐 https://www.ypsomed.com/en-AU/

TRADE PARTNER: HEALTH2SYNC

Health2Sync is a digital health solution provider dedicated to improving metabolic health management through data-driven care. For over 10 years, the Health2Sync Clinician Platform has supported more than 1,500 healthcare partners by streamlining data integration, enhancing workflow, and reducing the administrative burden for care teams.

Meanwhile, the Health2Sync Mobile App has empowered over 1.6 million users worldwide to effortlessly sync a wide range of health metrics and take greater control of their self-management.

🌐https://www.health2sync.com/

TRADE PARTNER: MEDTRONIC

Bold thinking. Bolder actions. We are Medtronic.

We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.

🌐 https://www.medtronic.com/au-en/index.html

TRADE PARTNER: INSULET & OMNIPOD

Meet Insulet & Omnipod® 5

Insulet Corporation, headquartered in Massachusetts, USA, is an innovative medical device company dedicated to simplifying life for people with diabetes through its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle.Insulet’s flagship innovation, the Omnipod® 5 Automated Insulin Delivery System, integrates with a choice of continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by the Omnipod 5 Controller (a phone-like device).

For more information, visit omnipod.com and request a call back from one of our Omnipod® 5 Product Specialists.

🌐 https://www.omnipod.com/